Skip to main content
Erschienen in: Annals of Surgical Oncology 4/2017

24.10.2016 | Gastrointestinal Oncology

Race Is a Risk for Lymph Node Metastasis in Patients With Gastric Cancer

verfasst von: Naruhiko Ikoma, MD, Mariela Blum, MD, Yi-Ju Chiang, MSPH, Jeannelyn S. Estrella, MD, Sinchita Roy-Chowdhuri, MD, Keith Fournier, MD, Paul Mansfield, MD, Jaffer Ajani, MD, Brian D. Badgwell, MD, MS

Erschienen in: Annals of Surgical Oncology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

The frequency of lymph node metastasis in each T stage of gastric cancer has not been as well described for Western populations as it has for Asian populations. This study aimed to determine these frequencies and to investigate risk factors associated with lymph node metastases in a racially diverse U.S. population.

Methods

A prospectively maintained database of 8260 patients with gastric or gastroesophageal junction adenocarcinoma treated at our institution from 1995 to 2013 was reviewed to identify those who underwent surgical resection without preoperative therapy. Associations between clinicopathologic variables and lymph node metastasis were tested with uni- and multivariate analyses.

Results

The study identified 218 patients with a pathologic diagnosis of gastric adenocarcinoma who underwent upfront gastrectomy. These study subjects included 115 white (53 %), 19 black (9 %), and 41 Asian (19 %) patients. At least 15 lymph nodes were examined in 148 (68 %) of the patients. The lymph node metastasis rates were 10 % for stage T1a, 34 % for stage T1b, 44 % for stage T2, 73 % for stage T3, and 95 % for stage T4 tumors. Univariate analysis showed that submucosal invasion, race, 15 or more lymph nodes examined, and lymphovascular invasion were associated with lymph node metastasis in T1 and T2 tumors. The multivariate analysis showed all but lymphovascular invasion to be independent risk factors for nodal metastasis.

Conclusions

The rates of lymph node metastasis observed in this study were higher than those reported in Asian reports. Race was an independent risk factor for lymph node metastasis. Caution is therefore needed when evidence from Asian countries is extrapolated to more racially diverse Western countries.
Literatur
1.
Zurück zum Zitat Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–25.CrossRefPubMed Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–25.CrossRefPubMed
2.
Zurück zum Zitat Choi KK, Bae JM, Kim SM, et al. The risk of lymph node metastases in 3951 surgically resected mucosal gastric cancers: implications for endoscopic resection. Gastrointest Endosc. 2016;83:896–901.CrossRefPubMed Choi KK, Bae JM, Kim SM, et al. The risk of lymph node metastases in 3951 surgically resected mucosal gastric cancers: implications for endoscopic resection. Gastrointest Endosc. 2016;83:896–901.CrossRefPubMed
3.
Zurück zum Zitat Choi AH, Nelson RA, Merchant SJ, Kim JY, Chao J, Kim J. Rates of lymph node metastasis and survival in T1a gastric adenocarcinoma in Western populations. Gastrointest. Endosc. 2016;83:1184–1192.CrossRefPubMed Choi AH, Nelson RA, Merchant SJ, Kim JY, Chao J, Kim J. Rates of lymph node metastasis and survival in T1a gastric adenocarcinoma in Western populations. Gastrointest. Endosc. 2016;83:1184–1192.CrossRefPubMed
4.
Zurück zum Zitat Fukuhara S, Yabe M, Montgomery MM, Itagaki S, Brower ST, Karpeh MS Jr. Race/Ethnicity is predictive of lymph node status in patients with early gastric cancer. J Gastrointest Surg. 2014;18:1744–51.CrossRefPubMed Fukuhara S, Yabe M, Montgomery MM, Itagaki S, Brower ST, Karpeh MS Jr. Race/Ethnicity is predictive of lymph node status in patients with early gastric cancer. J Gastrointest Surg. 2014;18:1744–51.CrossRefPubMed
5.
Zurück zum Zitat Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2010, version 3. Gastric Cancer. 2011;14:113–23.CrossRef Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2010, version 3. Gastric Cancer. 2011;14:113–23.CrossRef
6.
Zurück zum Zitat Ajani JA, Bentrem DJ, Besh S, et al. Gastric cancer, version 2013: featured updates to the NCCN Guidelines. JNCCN. 2013;11:531–46.PubMed Ajani JA, Bentrem DJ, Besh S, et al. Gastric cancer, version 2013: featured updates to the NCCN Guidelines. JNCCN. 2013;11:531–46.PubMed
7.
Zurück zum Zitat Boku T, Nakane Y, Okusa T, et al. Evaluation of the frequency of lymphnode metastasis and the number of metastasized lymph nodes in gastric carcinoma. Nihon Shoukakigeka Gakkaishi. 1990;23:841–50. Boku T, Nakane Y, Okusa T, et al. Evaluation of the frequency of lymphnode metastasis and the number of metastasized lymph nodes in gastric carcinoma. Nihon Shoukakigeka Gakkaishi. 1990;23:841–50.
8.
Zurück zum Zitat Hirasawa T, Gotoda T, Miyata S, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer. 2009;12:148–52.CrossRefPubMed Hirasawa T, Gotoda T, Miyata S, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer. 2009;12:148–52.CrossRefPubMed
9.
Zurück zum Zitat Shimada S, Yagi Y, Shiomori K, et al. Characterization of early gastric cancer and proposal of the optimal therapeutic strategy. Surgery. 2001;129:714–9.CrossRefPubMed Shimada S, Yagi Y, Shiomori K, et al. Characterization of early gastric cancer and proposal of the optimal therapeutic strategy. Surgery. 2001;129:714–9.CrossRefPubMed
10.
Zurück zum Zitat Namieno T, Koito K, Higashi T, Shimamura T, Yamashita K, Kondo Y. Tumor recurrence following resection for early gastric carcinoma and its implications for a policy of limited resection. World J Surg. 1998;22:869–73.CrossRefPubMed Namieno T, Koito K, Higashi T, Shimamura T, Yamashita K, Kondo Y. Tumor recurrence following resection for early gastric carcinoma and its implications for a policy of limited resection. World J Surg. 1998;22:869–73.CrossRefPubMed
11.
Zurück zum Zitat Ahmad R, Setia N, Schmidt BH, et al. Predictors of lymph node metastasis in western early gastric cancer. J Gastrointest Surg. 2016;20:531–8.CrossRefPubMed Ahmad R, Setia N, Schmidt BH, et al. Predictors of lymph node metastasis in western early gastric cancer. J Gastrointest Surg. 2016;20:531–8.CrossRefPubMed
12.
Zurück zum Zitat Folli S, Morgagni P, Roviello F, et al. Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the Italian Research Group for Gastric Cancer (IRGGC). Jpn J Clin Oncol. 2001;31:495–9.CrossRefPubMed Folli S, Morgagni P, Roviello F, et al. Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the Italian Research Group for Gastric Cancer (IRGGC). Jpn J Clin Oncol. 2001;31:495–9.CrossRefPubMed
13.
Zurück zum Zitat Holscher AH, Drebber U, Monig SP, Schulte C, Vallbohmer D, Bollschweiler E. Early gastric cancer: lymph node metastasis starts with deep mucosal infiltration. Ann Surg. 2009;250:791–7.CrossRefPubMed Holscher AH, Drebber U, Monig SP, Schulte C, Vallbohmer D, Bollschweiler E. Early gastric cancer: lymph node metastasis starts with deep mucosal infiltration. Ann Surg. 2009;250:791–7.CrossRefPubMed
14.
Zurück zum Zitat Wang J, Sun Y, Bertagnolli MM. Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database. Ann Surg Oncol. 2015;22:2965–71.CrossRefPubMed Wang J, Sun Y, Bertagnolli MM. Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database. Ann Surg Oncol. 2015;22:2965–71.CrossRefPubMed
15.
Zurück zum Zitat Kunz PL, Gubens M, Fisher GA, Ford JM, Lichtensztajn DY, Clarke CA. Long-term survivors of gastric cancer: a California population-based study. J Clin Oncol. 2012;30:3507–15.CrossRefPubMed Kunz PL, Gubens M, Fisher GA, Ford JM, Lichtensztajn DY, Clarke CA. Long-term survivors of gastric cancer: a California population-based study. J Clin Oncol. 2012;30:3507–15.CrossRefPubMed
16.
Zurück zum Zitat Maskarinec G, Noh JJ. The effect of migration on cancer incidence among Japanese in Hawaii. Ethn Dis. 2004;14:431–9.PubMed Maskarinec G, Noh JJ. The effect of migration on cancer incidence among Japanese in Hawaii. Ethn Dis. 2004;14:431–9.PubMed
17.
Zurück zum Zitat Lee J, Demissie K, Lu SE, Rhoads GG. Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea. Cancer Control. 2007;14:78–85.PubMed Lee J, Demissie K, Lu SE, Rhoads GG. Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea. Cancer Control. 2007;14:78–85.PubMed
18.
Zurück zum Zitat Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomark Prev. 2014;23:700–13.CrossRef Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomark Prev. 2014;23:700–13.CrossRef
19.
Zurück zum Zitat Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States? Cancer. 2000;89:2237–46.CrossRefPubMed Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States? Cancer. 2000;89:2237–46.CrossRefPubMed
Metadaten
Titel
Race Is a Risk for Lymph Node Metastasis in Patients With Gastric Cancer
verfasst von
Naruhiko Ikoma, MD
Mariela Blum, MD
Yi-Ju Chiang, MSPH
Jeannelyn S. Estrella, MD
Sinchita Roy-Chowdhuri, MD
Keith Fournier, MD
Paul Mansfield, MD
Jaffer Ajani, MD
Brian D. Badgwell, MD, MS
Publikationsdatum
24.10.2016
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 4/2017
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5645-x

Weitere Artikel der Ausgabe 4/2017

Annals of Surgical Oncology 4/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.